JPWO2022228497A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022228497A5 JPWO2022228497A5 JP2023565918A JP2023565918A JPWO2022228497A5 JP WO2022228497 A5 JPWO2022228497 A5 JP WO2022228497A5 JP 2023565918 A JP2023565918 A JP 2023565918A JP 2023565918 A JP2023565918 A JP 2023565918A JP WO2022228497 A5 JPWO2022228497 A5 JP WO2022228497A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- bonded
- pancreatic
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110482012 | 2021-04-30 | ||
| CN202110482012.2 | 2021-04-30 | ||
| PCT/CN2022/089737 WO2022228497A1 (zh) | 2021-04-30 | 2022-04-28 | 药物在治疗肿瘤疾病中的应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024516217A JP2024516217A (ja) | 2024-04-12 |
| JP2024516217A5 JP2024516217A5 (https=) | 2025-05-02 |
| JPWO2022228497A5 true JPWO2022228497A5 (https=) | 2025-05-02 |
Family
ID=83846722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565918A Pending JP2024516217A (ja) | 2021-04-30 | 2022-04-28 | 腫瘍疾患の治療における医薬の使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240238434A1 (https=) |
| EP (1) | EP4331614A4 (https=) |
| JP (1) | JP2024516217A (https=) |
| KR (1) | KR20240004657A (https=) |
| CN (2) | CN121490094A (https=) |
| AU (1) | AU2022263701B2 (https=) |
| BR (1) | BR112023022540A2 (https=) |
| CA (1) | CA3217111A1 (https=) |
| CL (2) | CL2023003211A1 (https=) |
| CO (1) | CO2023014715A2 (https=) |
| EC (1) | ECSP23082749A (https=) |
| GE (1) | GEAP202416383A (https=) |
| IL (1) | IL308098A (https=) |
| MX (1) | MX2023012797A (https=) |
| WO (1) | WO2022228497A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2025009780A (es) * | 2023-02-24 | 2025-09-02 | Sichuan Kelun Biotech Biopharmaceutical Co Ltd | Uso de un conjugado de farmaco en el tratamiento de una enfermedad tumoral y metodo |
| CN121127270A (zh) * | 2023-05-22 | 2025-12-12 | 四川科伦博泰生物医药股份有限公司 | 药物偶联物治疗肿瘤疾病的用途及方法 |
| WO2025002263A1 (zh) * | 2023-06-30 | 2025-01-02 | 默沙东有限责任公司 | 治疗组合及其用途和治疗方法 |
| WO2025209442A1 (zh) * | 2024-04-03 | 2025-10-09 | 四川科伦博泰生物医药股份有限公司 | 偶联物在治疗肿瘤疾病中的用途及方法 |
| WO2025241959A1 (zh) * | 2024-05-22 | 2025-11-27 | 四川科伦博泰生物医药股份有限公司 | 抗体药物偶联物在预防或治疗疾病中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7379795B2 (ja) * | 2016-04-27 | 2023-11-15 | イミューノメディクス、インコーポレイテッド | チェックポイント阻害薬に再発／耐性を示す腫瘍を治療するための抗Ｔｒｏｐ－２－ＳＮ－３８抗体薬物複合体の効果 |
| US11207420B2 (en) * | 2017-04-19 | 2021-12-28 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Cytotoxin and conjugate, uses of same and preparation method therefor |
| EP3725798B1 (en) * | 2017-12-15 | 2026-03-04 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Bioactive conjugate, preparation method therefor and use thereof |
| CN110903395A (zh) * | 2018-09-14 | 2020-03-24 | 四川科伦博泰生物医药股份有限公司 | 抗体、偶联物及其制备方法和用途 |
-
2022
- 2022-04-28 BR BR112023022540A patent/BR112023022540A2/pt unknown
- 2022-04-28 IL IL308098A patent/IL308098A/en unknown
- 2022-04-28 MX MX2023012797A patent/MX2023012797A/es unknown
- 2022-04-28 US US18/557,900 patent/US20240238434A1/en active Pending
- 2022-04-28 EP EP22794967.4A patent/EP4331614A4/en active Pending
- 2022-04-28 KR KR1020237040823A patent/KR20240004657A/ko active Pending
- 2022-04-28 GE GEAP202416383A patent/GEAP202416383A/en unknown
- 2022-04-28 WO PCT/CN2022/089737 patent/WO2022228497A1/zh not_active Ceased
- 2022-04-28 CN CN202610018019.1A patent/CN121490094A/zh active Pending
- 2022-04-28 AU AU2022263701A patent/AU2022263701B2/en active Active
- 2022-04-28 CN CN202280025989.4A patent/CN117157106A/zh active Pending
- 2022-04-28 CA CA3217111A patent/CA3217111A1/en active Pending
- 2022-04-28 JP JP2023565918A patent/JP2024516217A/ja active Pending
-
2023
- 2023-10-26 CL CL2023003211A patent/CL2023003211A1/es unknown
- 2023-10-30 CO CONC2023/0014715A patent/CO2023014715A2/es unknown
- 2023-10-30 EC ECSENADI202382749A patent/ECSP23082749A/es unknown
-
2025
- 2025-03-19 CL CL2025000805A patent/CL2025000805A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023070678A5 (https=) | ||
| WO2023109965A1 (zh) | 一种喜树碱类化合物及其偶联物 | |
| ES3054415T3 (en) | Anti-c-met antibody drug conjugates | |
| RU2018144315A (ru) | КОНЪЮГАТЫ АНТИТЕЛА К cMet И ЛЕКАРСТВЕННОГО СРЕДСТВА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| US20240091374A1 (en) | Anti-sez6 antibody drug conjugates | |
| WO2022199237A1 (zh) | 修饰的氨基酸及其在adc中的应用 | |
| WO2022237884A1 (zh) | 一种抗体药物偶联物及其制备方法和应用 | |
| WO2022228497A1 (zh) | 药物在治疗肿瘤疾病中的应用 | |
| JP2022513684A5 (https=) | ||
| KR20040091083A (ko) | 이리노테칸 히드로클로라이드의 결정성 다형체 | |
| TW201914592A (zh) | 阿帕替尼和c-Met抑制劑聯合在製備治療腫瘤的藥物中的用途 | |
| JPWO2021202984A5 (https=) | ||
| JPWO2022228497A5 (https=) | ||
| US20250228956A1 (en) | Pharmaceutical composition, and preparation method and use thereof | |
| KR20240012513A (ko) | 세스퀴테르펜 유도체, 그의 약학적 조성물 및 그의 제조 방법과 용도 | |
| CN108863992B (zh) | 多氨基多羧酸修饰卡巴他赛化合物的制备方法及用途 | |
| EP4710939A1 (en) | Combined therapy drug comprising anti-her2 bispecific antibody and use thereof | |
| CN110891944A (zh) | 用于治疗癌症的化合物、组合物及其用途 | |
| KR102092258B1 (ko) | 광감각제가 접합된 고분자를 유효성분으로 포함하는 면역증강제, 바이러스 감염 또는 암 예방 또는 치료용 백신 조성물 | |
| CN114191558A (zh) | Egfr抑制剂与抗血管新生药物在治疗肿瘤疾病的药物中的用途 | |
| WO2025036307A1 (zh) | 抗frα抗体药物偶联物在治疗疾病中的应用 | |
| JPWO2022250070A5 (https=) | ||
| WO2024240084A1 (zh) | 药物偶联物治疗肿瘤疾病的用途及方法 | |
| WO2024175042A1 (zh) | 药物偶联物治疗肿瘤疾病的用途及方法 | |
| BR112023022531B1 (pt) | CONJUGADO DE FÁRMACO E ANTICORPO ANTI-c-Met, COMPOSIÇÃO FARMACÊUTICA COMPREENDENDO OS MESMOS E SEU USO NO TRATAMENTO DE CÂNCER PULMONAR DE CÉLULAS NÃO PEQUENAS |